Table 3.
Estimated Treatment Effects Associated with Project Dulce in Health Insurance and A1c Simulation Cohorts
| Health Insurance | Uninsured Cohort | CMS Cohort | Medi-Cal Cohort | Commercial Cohort |
|---|---|---|---|---|
| Change from baseline in A1c (%-points) | −1.3 (2.5) | −0.8 (2.3) | −0.5 (1.9) | −0.4 (2.0) |
| Change from baseline in systolic blood pressure (mm Hg) | −3.1 (17.9) | −2.8 (21.5) | −1.9 (21.2) | −0.0 (16.8) |
| Change from baseline in total cholesterol (mg/dL) | −21.5 (52.3) | −12.9 (74.7) | −12.6 (53.9) | −4.1 (54.8) |
| Change from baseline in HDL-C (mg/dL) | −0.7 (12.2) | −1.9 (13.9) | −1.9 (3.6) | 0.0 (8.0) |
| Change from baseline in LDL-C (mg/dL) | −10.6 (40.4) | −8.0 (41.8) | −4.3 (42.1) | −2.2 (38.1) |
| Change from baseline in triglycerides (mg/dL) | −46.5 (162.2) | −26.0 (198.5) | −24.7 (175.9) | −11.3 (579.9) |
HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol. Values shown are means with standard deviation in parentheses.